ATE454629T1 - Immunoassay zur simultanen immunchemischen bestimmung eines analyten (antigen) und eines gegen den analyten gerichteten therapieantikörpers in proben (recovery immunoassay) - Google Patents

Immunoassay zur simultanen immunchemischen bestimmung eines analyten (antigen) und eines gegen den analyten gerichteten therapieantikörpers in proben (recovery immunoassay)

Info

Publication number
ATE454629T1
ATE454629T1 AT06828568T AT06828568T ATE454629T1 AT E454629 T1 ATE454629 T1 AT E454629T1 AT 06828568 T AT06828568 T AT 06828568T AT 06828568 T AT06828568 T AT 06828568T AT E454629 T1 ATE454629 T1 AT E454629T1
Authority
AT
Austria
Prior art keywords
immunoassay
analyte
antibody
antigen
treatment
Prior art date
Application number
AT06828568T
Other languages
German (de)
English (en)
Inventor
Pavel Strohner
Original Assignee
Pavel Strohner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pavel Strohner filed Critical Pavel Strohner
Application granted granted Critical
Publication of ATE454629T1 publication Critical patent/ATE454629T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT06828568T 2005-12-02 2006-11-29 Immunoassay zur simultanen immunchemischen bestimmung eines analyten (antigen) und eines gegen den analyten gerichteten therapieantikörpers in proben (recovery immunoassay) ATE454629T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005057920A DE102005057920A1 (de) 2005-12-02 2005-12-02 Immunoassay zur simultanen immunchemischen Bestimmung eines Analyten (Antigen) und eines gegen den Analyten gerichteten Therapieantikörpers in Proben
PCT/DE2006/002107 WO2007062628A2 (de) 2005-12-02 2006-11-29 Immunoassay zur simultanen immunchemischen bestimmung eines analyten (antigen) und eines gegen den analyten gerichteten therapieantikörpers in proben (recovery immunoassay)

Publications (1)

Publication Number Publication Date
ATE454629T1 true ATE454629T1 (de) 2010-01-15

Family

ID=37965064

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06828568T ATE454629T1 (de) 2005-12-02 2006-11-29 Immunoassay zur simultanen immunchemischen bestimmung eines analyten (antigen) und eines gegen den analyten gerichteten therapieantikörpers in proben (recovery immunoassay)

Country Status (7)

Country Link
US (1) US20080280311A1 (enExample)
EP (1) EP1957980B1 (enExample)
JP (1) JP4918556B2 (enExample)
AT (1) ATE454629T1 (enExample)
CA (1) CA2640835C (enExample)
DE (2) DE102005057920A1 (enExample)
WO (1) WO2007062628A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009034714A1 (de) * 2009-07-24 2011-01-27 Biotez Berlin-Buch Gmbh Biochemisch-Technologisches Zentrum Immunoassay zur Bestimmung des freien Targets (Antigen) in Proben, gegen das ein therapeutischer Antikörper gerichtet ist (Free Target Immunoassay)
AU2010315547C1 (en) 2009-10-26 2015-06-04 Société des Produits Nestlé S.A. Assays for the detection of anti-TNF drugs and autoantibodies
AU2011317149B2 (en) 2010-10-18 2015-05-07 Société des Produits Nestlé S.A. Methods for determining anti-drug antibody isotypes
DE102010050140A1 (de) 2010-11-03 2012-05-03 Biotez Berlin-Buch Gmbh Recovery Immunoassay zur gleichzeitigen immunchemischen Bestimmung eines Analyten (Antigen) und eines gegen den Analyten gerichteten Therapieantikörpers
RU2013158256A (ru) 2011-07-06 2015-07-10 Нестек С.А. АНАЛИЗЫ ДЛЯ ОБНАРУЖЕНИЯ НЕЙТРАЛИЗУЮЩИХ АУТОАНТИТЕЛ ДЛЯ БИОЛОГИЧЕСКОЙ ТЕРАПИИ TNFα
US20130266963A1 (en) * 2011-07-06 2013-10-10 Nestec S.A. Assay for detecting neutralizing autoantibodies to biologic therapy
ES2735085T3 (es) 2014-12-05 2019-12-16 Nestle Sa Ensayos de cambio de movilidad homogéneos indirectos para la detección de agentes biológicos en muestras de pacientes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4138712A1 (de) * 1991-11-20 1993-05-27 Pavel Dr Strohner Verfahren zur schnelloptimierung und gezielten qualitaetskontrolle von immunoassays aller provenienzen sowie vorrichtung zur durchfuehrung des verfahrens
JPH0772150A (ja) * 1993-09-02 1995-03-17 Tonen Corp ＩｇＥの測定方法
DE19532655A1 (de) * 1995-08-24 1997-02-27 Pavel Dr Strohner Verfahren zur zweidimensionalen Bestimmung von Proben in Immunoassays
US5945294A (en) * 1996-11-26 1999-08-31 Heska Corporation Method to detect IgE
US6127130A (en) * 1998-03-13 2000-10-03 The United States Of America As Represented By The Secretary Of The Navy Multiassay method for determining the concentrations of antigens and interferants
JP2002350447A (ja) * 2001-05-24 2002-12-04 Wako Pure Chem Ind Ltd 生理活性物質固定化担体及びその製造方法、固定化生理活性物質、試料中の対象成分分析方法、並びに試料中の対象成分分析用キット
GB0509512D0 (en) * 2005-05-10 2005-06-15 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
WO2007062628A3 (de) 2007-07-19
JP4918556B2 (ja) 2012-04-18
DE102005057920A1 (de) 2007-06-28
WO2007062628A2 (de) 2007-06-07
DE502006005889D1 (de) 2010-02-25
EP1957980B1 (de) 2010-01-06
EP1957980A2 (de) 2008-08-20
JP2009517667A (ja) 2009-04-30
US20080280311A1 (en) 2008-11-13
CA2640835C (en) 2014-03-18
CA2640835A1 (en) 2007-06-07

Similar Documents

Publication Publication Date Title
EP2210939A4 (en) Anti-bst2 antibody
EA201070687A1 (ru) Способ ингибирования лейкозных стволовых клеток
DE60130538D1 (de) Humanisierte antikörper gegen ccr2 und verfahren zur deren verwendung
BRPI0518994A2 (pt) anticorpos ou polipeptÍdeos que se ligam a br3, seus usos e formulaÇÕes lÍquidas
UA109633C2 (uk) Антитіло людини проти тканинного фактора
NZ596409A (en) Anti macrophage migration inhibitory factor antibodies
TW200639181A (en) Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
EA200600275A1 (ru) Цитотоксический конъюгат, специфичный по отношению к са6 антигену, и способы его применения
ATE441116T1 (de) Verfahren zur selektiven bestimmung von procalcitonin 1-116 für diagnostische zwecke sowie antikírper und kits zur ausführung dieses verfahrens
DK1446157T3 (da) Antistoffer til inhibering af blodkoagulation og fremgangsmåder til anvendelse deraf
ATE414106T1 (de) Pegylierte single-domain-antikörper (dab)
EA200600905A1 (ru) АНТИГЕНСВЯЗЫВАЮЩИЕ МОЛЕКУЛЫ, ОБЛАДАЮЩИЕ ПОВЫШЕННОЙ АФФИННОСТЬЮ К СВЯЗЫВАНИЮ С Fc-РЕЦЕПТОРОМ И ЭФФЕКТОРНОЙ ФУНКЦИЕЙ
WO2006078746A3 (en) Method, compositions and classification for tumor diagnostics and treatment
ATE505544T1 (de) Monoklonale antikörper und einzelkettenantikörper fragments gegen das zelloberflächen prostataspezifische membranantigen
WO2008017963A3 (en) Antigen binding molecules that bind egfr, vectors encoding same, and uses thereof
WO2006066078A3 (en) Fcϝriib-specific antibodies and methods of use thereof
DK1565489T3 (da) Internaliserende antistoffer specifikke for RAAG10-celleoverflademålet
DE602004025101D1 (de) Humane anti-humane cd3-bindungsmoleküle
EP2295465A3 (en) Human monoclonal antibodies to influenza M2 protein and methods of making and using same
NZ594466A (en) Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies
ATE556717T1 (de) Neutralisierung monoklonaler antikörper gegen mit schwerem akutem respirationssyndrom assoziiertem coronavirus
WO2008151819A3 (en) Treatment of tumors using specific anti-l1 antibody
BRPI0407680A (pt) métodos para diagnóstico de cáncer e diminuição de metástase por células cancerosas
TW200720439A (en) Antigen binding molecules directed to mcsp and having increased fc receptor binding affinity and effector function
ATE454629T1 (de) Immunoassay zur simultanen immunchemischen bestimmung eines analyten (antigen) und eines gegen den analyten gerichteten therapieantikörpers in proben (recovery immunoassay)